Henry Rosevear

Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non–muscle invasive bladder cancer

Andrew J. Lightfoot, Benjamin N. Breyer, Henry Rosevear et al. · Urologic Oncology Seminars and Original Investigations · 2013 · 123 citations

Medicine, Oncology, Urology +16

Bacillus Calmette-Guérin With or Without Interferon α-2b and Megadose Versus Recommended Daily Allowance Vitamins During Induction and Maintenance Intravesical Treatment of Nonmuscle Invasive Bladder Cancer

Kenneth G. Nepple, Andrew J. Lightfoot, Henry Rosevear et al. · The Journal of Urology · 2010 · 122 citations

Medicine, Oncology, Urology +8

Utility of the RENAL nephrometry scoring system in the real world: predicting surgeon operative preference and complication risk

Henry Rosevear, Paul T. Gellhaus, Andrew J. Lightfoot et al. · British Journal of Urology · 2011 · 100 citations

Medicine, Surgery, Urology +15

Success of Ureteral Stents for Intrinsic Ureteral Obstruction

David Wenzler, Simon P. Kim, Henry Rosevear et al. · Journal of Endourology · 2008 · 65 citations · Full text

Medicine, Surgery, Urology +8

Retrograde Ureteral Stents for Extrinsic Ureteral Obstruction: Nine Years’ Experience at University of Michigan

Henry Rosevear, Simon P. Kim, David Wenzler et al. · Urology · 2007 · 65 citations

Medicine, Surgery, Urology +9